These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 30995638

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R, Martinez-Osorio J, Yuan CM, Little DJ, Watson MA, Agodoa L, Abbott KC.
    Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
    [Abstract] [Full Text] [Related]

  • 24. APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.
    Mukamal KJ, Tremaglio J, Friedman DJ, Ix JH, Kuller LH, Tracy RP, Pollak MR.
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):398-403. PubMed ID: 26634651
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
    Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, Kopp JB, Winkler CA, Nelson GW, Johnson RC, Palmer ND, Hicks PJ, Bostrom MA, Cooke JN, McDonough CW, Bowden DW.
    PLoS Genet; 2011 Jun; 7(6):e1002150. PubMed ID: 21698141
    [Abstract] [Full Text] [Related]

  • 28. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
    Riella LV, Sheridan AM.
    Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
    [Abstract] [Full Text] [Related]

  • 29. Target organ damage in African American hypertension: role of APOL1.
    Freedman BI, Murea M.
    Curr Hypertens Rep; 2012 Feb; 14(1):21-8. PubMed ID: 22068337
    [Abstract] [Full Text] [Related]

  • 30. Clinical Genetic Testing for APOL1: Are we There Yet?
    Young BA, Fullerton SM, Wilson JG, Cavanaugh K, Blacksher E, Spigner C, Himmelfarb J, Burke W.
    Semin Nephrol; 2017 Nov; 37(6):552-557. PubMed ID: 29110763
    [Abstract] [Full Text] [Related]

  • 31. Genetic variation in APOL1 associates with younger age at hemodialysis initiation.
    Kanji Z, Powe CE, Wenger JB, Huang C, Ankers E, Sullivan DA, Collerone G, Powe NR, Tonelli M, Bhan I, Bernhardy AJ, Dibartolo S, Friedman D, Genovese G, Pollak MR, Thadhani R.
    J Am Soc Nephrol; 2011 Nov; 22(11):2091-7. PubMed ID: 21997398
    [Abstract] [Full Text] [Related]

  • 32. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
    Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR.
    Science; 2010 Aug 13; 329(5993):841-5. PubMed ID: 20647424
    [Abstract] [Full Text] [Related]

  • 33. Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
    Bonomo JA, Ng MC, Palmer ND, Keaton JM, Larsen CP, Hicks PJ, T2D-GENES Consortium, Langefeld CD, Freedman BI, Bowden DW.
    Clin J Am Soc Nephrol; 2014 Aug 07; 9(8):1434-40. PubMed ID: 24948143
    [Abstract] [Full Text] [Related]

  • 34. Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.
    Nadkarni GN, Chauhan K, Verghese DA, Parikh CR, Do R, Horowitz CR, Bottinger EP, Coca SG.
    Kidney Int; 2018 Jun 07; 93(6):1409-1416. PubMed ID: 29685497
    [Abstract] [Full Text] [Related]

  • 35. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
    Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND, Palanisamy A, Reeves-Daniel AM, Brown WM, Divers J.
    Transplantation; 2016 Jan 07; 100(1):194-202. PubMed ID: 26566060
    [Abstract] [Full Text] [Related]

  • 36. FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes.
    Chan GC, Divers J, Russell GB, Langefeld CD, Wagenknecht LE, Hsu FC, Xu J, Smith SC, Palmer ND, Hicks PJ, Bowden DW, Register TC, Ma L, Carr JJ, Freedman BI.
    Diabetes Care; 2018 Jan 07; 41(1):178-186. PubMed ID: 29113983
    [Abstract] [Full Text] [Related]

  • 37. Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American Women.
    Franceschini N, Kopp JB, Barac A, Martin LW, Li Y, Qian H, Reiner AP, Pollak M, Wallace RB, Rosamond WD, Winkler CA.
    JAMA Cardiol; 2018 Aug 01; 3(8):712-720. PubMed ID: 29971324
    [Abstract] [Full Text] [Related]

  • 38. The APOL1 gene and allograft survival after kidney transplantation.
    Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin JJ, Kiger DF, Gautreaux MD, Divers J, Freedman BI.
    Am J Transplant; 2011 May 01; 11(5):1025-30. PubMed ID: 21486385
    [Abstract] [Full Text] [Related]

  • 39. Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.
    Locke JE, Sawinski D, Reed RD, Shelton B, MacLennan PA, Kumar V, Mehta S, Mannon RB, Gaston R, Julian BA, Carr JJ, Terry JG, Kilgore M, Massie AB, Segev DL, Lewis CE.
    Ann Surg; 2018 Jun 01; 267(6):1161-1168. PubMed ID: 28187045
    [Abstract] [Full Text] [Related]

  • 40. Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.
    Young BA, Blacksher E, Cavanaugh KL, Freedman BI, Fullerton SM, Kopp JB, Umeukeje EM, West KM, Wilson JG, Burke W, APOL1 Stakeholders Project.
    Am J Nephrol; 2019 Jun 01; 50(4):303-311. PubMed ID: 31480040
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.